Table 3.
Current exercise discussionb |
Preferred exercise discussionb |
|||||
---|---|---|---|---|---|---|
ORc | 95% CIc | P valuec | ORc | 95% CIc | P valuec | |
Sex | ||||||
Female (reference) | 1.000 | 1.000 | ||||
Male | 1.562 | (0.93-2.61) | 0.089 | 1.709 | (0.97-3.01) | 0.064 |
Age (years) | ||||||
<65 (reference) | 1.000 | 1.000 | ||||
≥65 | 1.025 | (0.58-1.82) | 0.933 | 1.339 | (0.73-2.45) | 0.344 |
Body mass index (kg/m2) | ||||||
Underweight (reference) | 1.000 | 1.000 | ||||
Normal weight | 1.929 | (0.57-6.51) | 0.290 | 0.804 | (0.22-2.92) | 0.741 |
Overweight | 2.350 | (0.67-8.20) | 0.180 | 0.656 | (0.17-2.47) | 0.532 |
Obese | 2.313 | (0.62-8.61) | 0.211 | 1.724 | (0.40-7.37) | 0.463 |
Education | ||||||
Up to age 14 years (reference) | 1.000 | 1.000 | ||||
Beyond age 14 years | 1.377 | (0.86-2.20) | 0.179 | 1.778 | (1.06-2.99) | 0.030 |
Marital status | ||||||
Married (reference) | 1.000 | 1.000 | ||||
Single | 0.643 | (0.33-1.25) | 0.194 | 1.151 | (0.51-2.60) | 0.735 |
Divorced | 0.950 | (0.44-2.08) | 0.898 | 1.013 | (0.42-2.46) | 0.978 |
Widowed | 0.759 | (0.29-1.97) | 0.572 | 0.638 | (0.23-1.75) | 0.383 |
Occupational status | ||||||
Retired (reference) | 1.000 | 1.000 | ||||
Homemaker | 1.150 | (0.49-2.68) | 0.746 | 0.888 | (0.36-2.18) | 0.796 |
Part-time | 4.559 | (1.63-12.72) | 0.004 | 17.786 | (2.18-145.03) | 0.007 |
Full-time | 2.024 | (1.06-3.88) | 0.034 | 2.036 | (0.99-4.17) | 0.052 |
Other | 1.438 | (0.36-5.71) | 0.606 | 6.430 | (0.70-59.01) | 0.100 |
Income adequacy | ||||||
Inadequate (reference) | 1.000 | 1.000 | ||||
Adequate | 0.927 | (0.58-1.48) | 0.751 | 0.860 | (0.51-1.45) | 0.569 |
Physical activity frequency | ||||||
<1 time/week (reference) | 1.000 | 1.000 | ||||
1-2 times/week | 1.551 | (0.90-2.68) | 0.115 | 1.758 | (0.94-3.28) | 0.076 |
>2 times/week | 1.713 | (0.99-2.94) | 0.050 | 1.059 | (0.59-1.91) | 0.848 |
Tumor sited | ||||||
Breast (reference) | 1.000 | 1.000 | ||||
Lung | 3.508 | (1.36-9.05) | 0.009 | 0.623 | (0.20-1.94) | 0.414 |
Colorectal | 2.308 | (0.74-7.25) | 0.152 | 1.190 | (0.27-5.30) | 0.820 |
Upper gastrointestinal area | 0.982 | (0.39-2.46) | 0.969 | 0.776 | (0.25-2.37) | 0.656 |
Urogenital | 2.322 | (0.61-8.90) | 0.219 | 0.479 | (0.10-2.30) | 0.358 |
Other | 0.765 | (0.23-2.53) | 0.660 | 0.406 | (0.10-1.67) | 0.211 |
Stage of disease | ||||||
Remission (reference) | 1.000 | 1.000 | ||||
Early | 1.135 | (0.48-2.70) | 0.775 | 1.753 | (0.62-4.96) | 0.290 |
Advanced | 0.602 | (0.28-1.28) | 0.188 | 0.612 | (0.26-1.46) | 0.270 |
Metastatic | 0.677 | (0.34-1.36) | 0.272 | 0.696 | (0.31-1.58) | 0.385 |
Unknown | 0.569 | (0.25-1.28) | 0.174 | 0.546 | (0.21-1.40) | 0.207 |
Chemotherapy | ||||||
No (reference) | 1.000 | 1.000 | ||||
Yes | 0.892 | (0.51-1.56) | 0.687 | 0.864 | (0.46-1.61) | 0.647 |
Surgery | ||||||
No (reference) | 1.000 | 1.000 | ||||
Yes | 0.851 | (0.50-1.44) | 0.548 | 1.348 | (0.74-2.47) | 0.335 |
Radiotherapy | ||||||
No (reference) | 1.000 | 1.000 | ||||
Yes | 1.209 | (0.72-2.04) | 0.475 | 1.007 | (0.56-1.81) | 0.982 |
Hormonotherapy | ||||||
No (reference) | 1.000 | 1.000 | ||||
Yes | 1.071 | (0.42-2.76) | 0.888 | 2.458 | (0.67-8.98) | 0.174 |
Other therapies | ||||||
No (reference) | 1.000 | 1.000 | ||||
Yes | 0.774 | (0.417-1.43) | 0.415 | 1.410 | (0.72-2.76) | 0.315 |
Adherence to guideline | ||||||
No (reference) | 1.000 | 1.000 | ||||
Yes | 1.221 | (0.55-2.71) | 0.624 | 1.471 | (0.58-3.6) | 0.420 |
Leisure Score Index | ||||||
<24 (reference) | 1.000 | 1.000 | ||||
≥24 | 1.415 | (0.55-3.68) | 0.476 | 1.002 | (0.34-2.99) | 0.997 |
Time from diagnosis | ||||||
≤30 m (reference) | 1.000 | 1.000 | ||||
>30 m | 1.295 | (0.78-2.15) | 0.315 | 1.021 | (0.58-1.80) | 0.942 |
CI, confidence interval; OR, odds ratio.
Current and preferred exercise discussion classified as yes, oncologist-initiated discussion/yes, initiated by me versus no.
Each variable was mutually adjusted for the following variables if not otherwise specified: sex (male, female); age (<65 years versus ≥65 years); education (≥high school versus <lower than high school); patient’s address (outside the city, city dweller); perceived income adequacy (adequate versus nonadequate); marital status (married, unmarried, divorced, widow); occupational status (retired, stay at home, part-time employed, full-time employed, other); frequency of sweating-inducing activity (<1 time/week; 1-2 times/week; >2 times/week); adherence to guidelines (yes versus no); Leisure Score Index (<24 versus ≥24); tumor site (breast, lung, colorectal, upper gastrointestinal area, urogenital, other); stage of the disease (remission, early, advanced, metastatic, unknown); chemotherapy (yes versus no); surgery (yes versus no); radiotherapy (yes versus no); hormone therapy (yes versus no); other treatments (yes versus no); treatment status (ended, incoming, ongoing, undefined); time from diagnosis (≤30 months, >30 months).
OR and CI and P value from the logistic regression model.
Tumor sites with <10 patients are classified as ‘other’.